BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38869161)

  • 1. EXPRESS: Epidemiology, Diagnosis and Management of Cardiac Amyloidosis.
    Bashir Z; Younus A; Dhillon S; Kasi A; Bukhari S
    J Investig Med; 2024 Jun; ():10815589241261279. PubMed ID: 38869161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac amyloidosis: state-of-the-art review.
    Bukhari S
    J Geriatr Cardiol; 2023 May; 20(5):361-375. PubMed ID: 37397865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the diagnosis and management of amyloid cardiomyopathy.
    Nijst P; Tang WW
    Fac Rev; 2021; 10():31. PubMed ID: 33817700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of pathways to facilitate early diagnosis and treatment of patients with cardiac amyloidosis.
    Kwok CS; Moody WE
    Ther Adv Cardiovasc Dis; 2023; 17():17539447231216318. PubMed ID: 38099406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis.
    Bistola V; Parissis J; Foukarakis E; Valsamaki PN; Anastasakis A; Koutsis G; Efthimiadis G; Kastritis E
    Heart Fail Rev; 2021 Jul; 26(4):861-879. PubMed ID: 33452596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, Incidence, and Impact on Mortality of Conduction System Disease in Transthyretin Cardiac Amyloidosis.
    Donnellan E; Wazni OM; Saliba WI; Hanna M; Kanj M; Patel DR; Wilner B; Kochar A; Jaber WA
    Am J Cardiol; 2020 Aug; 128():140-146. PubMed ID: 32650908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transthyretin cardiac amyloidosis.
    Porcari A; Fontana M; Gillmore JD
    Cardiovasc Res; 2023 Feb; 118(18):3517-3535. PubMed ID: 35929637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis.
    Zhang KW; Stockerl-Goldstein KE; Lenihan DJ
    JACC Basic Transl Sci; 2019 Jun; 4(3):438-448. PubMed ID: 31312767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal Imaging and Biomarkers in Cardiac Amyloidosis.
    Jung MH; Chang S; Han EJ; Youn JC
    Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid cardiomyopathy.
    Kristen AV
    Herz; 2020 May; 45(3):267-271. PubMed ID: 32107564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis.
    Papathanasiou M; Jakstaite AM; Oubari S; Siebermair J; Wakili R; Hoffmann J; Carpinteiro A; Hagenacker T; Thimm A; Rischpler C; Kessler L; Rassaf T; Luedike P
    ESC Heart Fail; 2022 Jun; 9(3):1740-1748. PubMed ID: 35178887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis.
    Lioncino M; Monda E; Palmiero G; Caiazza M; Vetrano E; Rubino M; Esposito A; Salerno G; Dongiglio F; D'Onofrio B; Verrillo F; Cerciello G; Manganelli F; Pacileo G; Bossone E; Golino P; Calabrò P; Limongelli G
    Heart Fail Clin; 2022 Jan; 18(1):73-87. PubMed ID: 34776085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring cardiac amyloidosis with multimodality imaging.
    Starr N; Ioannou A; Martinez-Naharro A
    Rev Esp Cardiol (Engl Ed); 2024 Jan; 77(1):79-87. PubMed ID: 37696332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narrative review of pharmacotherapy for transthyretin cardiac amyloid.
    Cruz Rodriguez JB; Tallaj JA
    Ann Transl Med; 2021 Mar; 9(6):519. PubMed ID: 33850916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure to Confirm Typical Echocardiographic Findings of Cardiac Amyloidosis in an Unresolved Nonischemic Cardiomyopathy Associated With Smoldering Multiple Myeloma: A Case Report.
    Gaibor C; Evbayekha E; Dixon B
    Cureus; 2023 Sep; 15(9):e44845. PubMed ID: 37818527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac Amyloidosis Treatment.
    Stern LK; Patel J
    Methodist Debakey Cardiovasc J; 2022; 18(2):59-72. PubMed ID: 35414852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and clinical outcomes of transthyretin amyloidosis: a systematic review and meta-analysis.
    Antonopoulos AS; Panagiotopoulos I; Kouroutzoglou A; Koutsis G; Toskas P; Lazaros G; Toutouzas K; Tousoulis D; Tsioufis K; Vlachopoulos C
    Eur J Heart Fail; 2022 Sep; 24(9):1677-1696. PubMed ID: 35730461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart of the Matter: Decoding the Underdiagnosed Cardiac Amyloidosis.
    Kaiser ME; Lewis TJ
    Cureus; 2023 Dec; 15(12):e50527. PubMed ID: 38098740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report.
    Kavita A; Abdul Onny MA; Suppiah S; Abdul Aziz AF; Hashim H; Raja Shariff RE; Ng CS
    Med J Malaysia; 2021 Sep; 76(5):762-767. PubMed ID: 34508392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.